In breast cancer, a recent study analyzing SLC34A2 gene expression in 146 breast tumor samples hypothesizes that this gene encoding NaPi2b antigen may be involved in the development of breast cancer and metastasis and suggests NaPi2b as a novel marker for detection of breast cancer and a target for therapeutic strategies [29]. This evidence concerns the gene SLC34A2 and breast neoplasm.